Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Intensity Therapeutics Inc (NASDAQ: INTS) was $0.4 for the day, down -6.10% from the previous closing price of $0.42. In other words, the price has decreased by -$6.10 from its previous closing price. On the day, 2.07 million shares were traded. INTS stock price reached its highest trading level at $0.42 during the session, while it also had its lowest trading level at $0.3851.
Ratios:
Our analysis of INTS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.60. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INTS now has a Market Capitalization of 23755694 and an Enterprise Value of 16806694.
Stock Price History:
The Beta on a monthly basis for INTS is 4.38, which has changed by -0.8489957 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, INTS has reached a high of $3.18, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is 10.04%, while the 200-Day Moving Average is calculated to be -50.07%.
Shares Statistics:
INTS traded an average of 29.97M shares per day over the past three months and 4176650 shares per day over the past ten days. A total of 60.06M shares are outstanding, with a floating share count of 53.63M. Insiders hold about 10.72% of the company’s shares, while institutions hold 4.92% stake in the company. Shares short for INTS as of 1763078400 were 3588277 with a Short Ratio of 0.56, compared to 1760486400 on 2253998. Therefore, it implies a Short% of Shares Outstanding of 3588277 and a Short% of Float of 6.1899999999999995.
Earnings Estimates
The company has 3.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.32 and -$0.37 for the fiscal current year, implying an average EPS of -$0.34. EPS for the following year is -$0.22, with 2.0 analysts recommending between -$0.19 and -$0.25.
